Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02584231Phase 4Completed
Phase 4, open-label trial of desmopressin in nocturnal enuresis (NE) (2 arms), sponsored by Ghent University. Primary endpoint: Desmopressin plasma concentrations at 24 hours. Started Sep 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02584231.